Clinical Trial: Genomic Analysis of Pediatric Bone Tumors
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Genomic Analysis of Pediatric Bone Tumors (Other Title: Pediatric Bone Tumor Biology Study)
Brief Summary: To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
Detailed Summary:
Sponsor: Stanford University
Current Primary Outcome:
- % necrosis post chemotherapy [ Time Frame: his is measured at the time of sample collection since we are looking for % necrosis in the sample we are collecting ]
- overall survival and event free survival [ Time Frame: This is measured at the time the patient dies, or at the time when patient relapses from their disease. There is no set time since this outcome is individually assessed. ]
Original Primary Outcome:
- % necrosis post chemotherapy [ Time Frame: This is measured at the time of sample collection since we are looking for % necrosis in the sample we are collecting ]
- overall survival and event free survival [ Time Frame: This is measured at the time the patient dies, or at the time when patient relapses from their disease. There is no set time since this outcome is individually assessed. ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Stanford University
Dates:
Date Received: January 11, 2010
Date Started: August 2007
Date Completion: August 2016
Last Updated: April 22, 2016
Last Verified: April 2016
